LANREOTIDE
lanreotide 60 mg/0.5 mL injection, 0.5 mL syringe
LANREOTIDE (11315M)
11315M
Manner of administration:Injection
Restriction (Streamlined authority code: 16024)
Indication: Acromegaly
Treatment phase: Initial treatment
Restriction (Streamlined authority code: 16055)
Indication: Acromegaly
Treatment phase: Continuing treatment
Restriction (Streamlined authority code: 16057)
Indication: Functional carcinoid tumour
Treatment phase: Initial treatment
Restriction (Streamlined authority code: 15955)
Indication: Functional carcinoid tumour
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 2 | # of repeats: 5 | DPMQ: $1,748.34 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||
|
|
|||||